Evidence map›Paper›PMID 35267656›Full record

ArticleCancers2022

Testing for Lynch Syndrome in Endometrial Carcinoma: From Universal to Age-Selective

Annukka Pasanen, Mikko Loukovaara, Elina Kaikkonen, Alisa Olkinuora, Kirsi Pylvänäinen, Pia Alhopuro, Päivi Peltomäki, Jukka-Pekka Mecklin, Ralf Bützow

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Cancers · 2023
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Annukka PasanenDepartment of Pathology, Helsinki University Hospital, University of Helsinki, 00290 Helsinki, Finland.
Mikko LoukovaaraDepartment of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, 00290 Helsinki, Finland.
Elina KaikkonenLaboratory of Genetics, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, 00209 Helsinki, Finland.
Alisa OlkinuoraDepartment of Medical and Clinical Genetics, University of Helsinki, 00014 Helsinki, Finland.ORCID 0000-0003-3987-9924
Kirsi PylvänäinenDepartment of Education and Science, Central Finland Health Care District, 40620 Jyväskylä, Finland.ORCID 0000-0003-4399-9283
Pia AlhopuroLaboratory of Genetics, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, 00209 Helsinki, Finland.
Päivi PeltomäkiDepartment of Medical and Clinical Genetics, University of Helsinki, 00014 Helsinki, Finland.
Jukka-Pekka MecklinDepartment of Surgery, Central Finland Health Care District; 40620 Jyväskylä, Finland.
Ralf BützowDepartment of Pathology, Helsinki University Hospital, University of Helsinki, 00290 Helsinki, Finland.
University of Helsinki · FICentral Finland Health Care District · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

International guidelines recommend universal screening of endometrial carcinoma (EC) patients for Lynch syndrome (LS). This screening is generally based on mismatch repair (MMR) protein immunohistochemistry followed by

Indexed as

endometrial carcinomaLynch syndrome screeningMLH1 immunohistochemistryMLH1 methylation analysis

Identifiers

PMID35267656
PMCPMC8909331
OpenAlexW4221019459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.